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THE WARREN SHUNT: EFFECT OF ALCOHOLISM
ON PORTAL PERFUSION
ABSTRACT
Kawasaki, S., Henderson, J.M., Hertzler, G. and Galloway, J.R. (1991) The role of
continued drinking in loss of portal perfusion after distal splenorenal shunt.
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Fifty percent of patients with alcoholic cirrhosis who undergo distal splenorenal
shunting for variceal bleeding lose portal perfusion within 1 year. Although it was
previously considered that this loss of portal flow was irrevocable, the present study
shows that with resolution of alcoholic hepatitis, portal perfusion can be restored. A
34-year-old patient with alcoholic liver disease and a distal splenorenal shunt lost
portal perfusion 1 year after the operation. He had continued to drink alcohol and
had high sinusoidal pressure. Following forced abstinence over the next 2 years, his
sinusoidal pressure fell, liver colume decreased, results of liver biopsy improved,
and portal perfusion was restored. Shunt patency was documented, and the same
collaterals from the portal vein to the shunt could still be visualized as had been seen
when portal flow ws absent. Restoration of portal perfusion was attributed to
decreased intrahepatic resistance secondary to abstinence from alcohol. A return to
drinking in the next 9 months led to alcoholic hepatitis and once again loss of portal
perfusion. This study places emphasis on increased intrahepatic resistance rather
than the development of portal-to-shunt collaterals as important in the loss of portal
flow in such patients.
PAPER DISCUSSION
KEY WORDS: Portacaval shunt, distal splenorenal shunt, portal hypertension,
alcoholic liver disease
There is little dispute about the ability of the distal splenorenal shunt (DSRS) to
prevent recurrent gastro-oesophageal bleeding from varices and portal hyperten-
sive gastropathyTM. This is achieved with a low incidence of postshunt encephalo-
pathy. However, the conceptual validity of maintained selective gastro-oesophageal
decompression has been challenged5’6. This is particularly so in the case of DSRS in
patients with alcoholic cirrhosis, with reported loss of prograde portal venous
perfusion in 50% to 70% of these patients7’8.
In general persistence of prograde portal venous perfusion after DSRS depends
on a favourable ratio between /intrahepatic resistance and portomesenteric-
gastrosplenic collateral (PM-GS) resistance. Maintained portomesenteric venous
hypertension after DSRS provides the stimulus for the inexorable further develop-
ment of potentially hepatofugal collaterals. Technical details of the operation are
important in the prevention of loss of prograde portal venous perfusion. Inokuchi et
al. and Warren et al.1 reported the potential importance of transpancreatic
collaterals, the "pancreatic siphon", and the Emory group have reported the
beneficial effects of complete splenopancreatic disconnection (SPD) in preventing
loss of prograde portal venous perfusion in alcoholic cirrhotics1.
The importance of gastro-spleno-colic disconnection to prevent the development
of a potentially massive hepatofugal epiploic to shunt portal venous "steal" has
been emphasized2, and left gastric (coronary) veins may be multiple and must be
sought and divided assiduously. Postoperative portal vein thrombosis is another
cause of loss of prograde portal venous perfusion2’3 but its occurrence is not
frequent and has not been correlated clearly with the method of dealing with the
stump of the splenic vein. Two other major identifiable PM-GS collateral pathways
are transgastric and retroperitoneal, but these are not addressable by technical
manoeuvres.72 HPB INTERNATIONAL
In the paper under review the Emory group have provided compelling evidence,
on the basis of one carefully studied patient, for another important factor in the loss
of prograde portal venous perfusion in patients with alcoholic liver disease
undergoing DSRS. They have clearly documented the loss of prograde portal
yenous perfusion due to the increased sinusoidal resistance associated with acute
alcoholic hepatopathy, the reversal of this loss following resolution of acute
hepatopathy during unequivocal abstinence from alcohol, and the reappearance of
hepatofugal flow with resumption of alcohol abuse. The authors state that this case
is representative of patients who have reversible liver disease, but that these
observations are probably not applicable to patients with stable or advanced
cirrhosis.
My experience with DSRS in 141 patients, 76 having established alcoholic
cirrhosis, suggests that the latter statement is not necessarily correct3’4.
Superimposed acute alcoholic hepatitis was present on admission in the majority of
these patients. Patients were kept in hospital before shunting for 1 to 24 weeks,
mean 6 weeks, until maximal clinical and biochemical improvement had occurred
and liver biopsies showed resolution of acute alcoholic hepatitis. On admission
50% of these patients were Childs grade C and 40% were Childs grade B. At
operation, after due preparation, only 1 patient remained in Childs category C and
57% had improved to Childs grade A.
Serial longitudinal studies of hepatic arterial and portal venous perfusion were
performed up to 10 years after DSRS in 63 patients, using dimethyltriamine
pentaacetic acid (DTPA) flow scintigraphy. Although failure to demonstrate
prograde portal venous perfusion was seen only in patients with alcoholic cirrhosis,
it was not as frequent as reported elsewhere (23%), it did not correlate with the
degree of collateralization or the occurrence of portosystemic encephalopathy, and
it was not progressive with time following operation. Furthermore there was no
statistically significant effect of splenopancreatic disconnection, on either the
incidence of loss of prograde portal perfusion, or on the absolute values of the T3
indices in 22 alcoholics and 22 non-alcoholics studied at different times after
operation.
The policy of adequate, and if necessary, prolonged in-hospital preoperative
preparation in this series is probably unique. It is felt that this policy, and regular
and personal postoperative surveillance, have played a major role in the remark-
able degree of durable postoperative abstinence from alcohol seen in the series.
This in turn may have contributed largely to the differences observed between the
DTPA portal venous perfusion data and the angiographic perfusion data reported
in other series. The findings in the remarkable case study reviewed here lend
further credence to this postulate.
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SHOULD LAPAROSCOPIC SURGERY BE AN
OUTPATIENT PROCEDURE?
ABSTRACT
Reddick, E.J. and Olsen, D.O. (1990) Outpatient laparoscopic laser cholecystec-
tomy. The American Journal of Surgery, 160, 485-489.
Laparoscopic laser cholecystectomy has been performed clinically in the United
States since 1988. After refinement of the technique, the procedure was offered on an
outpatient basis. Eighty-three patients underwent laparoscopic laser cholecystec-
tomy during the study period. Thirty-seven (45%) had the procedure as an
outpatient. Younger patients were more suited for the outpatient procedure and
those without previous surgery were more likely to have the procedure done as an
outpatient. Weight, operating time, and gallbladder pathology were similar,
although patients with acute inflammation of the gallbladder were more likely to
require hospitalization. The primary reason for patient admission was patient
preference.